128 related articles for article (PubMed ID: 26157778)
1. Bortezomib inhibits the survival and proliferation of bone marrow stromal cells.
Kim HY; Moon JY; Ryu H; Choi YS; Song IC; Lee HJ; Yun HJ; Kim S; Jo DY
Blood Res; 2015 Jun; 50(2):87-96. PubMed ID: 26157778
[TBL] [Abstract][Full Text] [Related]
2. The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
Ren Z; Lantermans H; Kuil A; Kraan W; Arenzana-Seisdedos F; Kersten MJ; Spaargaren M; Pals ST
J Hematol Oncol; 2021 Jan; 14(1):11. PubMed ID: 33436043
[TBL] [Abstract][Full Text] [Related]
3. [Effect of mesenchymal stem cells on multiple myeloma cells growth and inhibition of bortezomib induced cell apoptosis].
Hao M; Xie ZQ; Han YJ; An G; Meng HX; Huang J; Li CH; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2010 Oct; 31(10):680-3. PubMed ID: 21223719
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression.
Hao M; Zhang L; An G; Meng H; Han Y; Xie Z; Xu Y; Li C; Yu Z; Chang H; Qiu L
Leuk Lymphoma; 2011 Sep; 52(9):1787-94. PubMed ID: 21534877
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.
Cui X; Chen J; Zacharek A; Li Y; Roberts C; Kapke A; Savant-Bhonsale S; Chopp M
Stem Cells; 2007 Nov; 25(11):2777-85. PubMed ID: 17641243
[TBL] [Abstract][Full Text] [Related]
6. Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen.
Gebraad A; Ohlsbom R; Miettinen JJ; Emeh P; Pakarinen TK; Manninen M; Eskelinen A; Kuismanen K; Slipicevic A; Lehmann F; Nupponen NN; Heckman CA; Miettinen S
Cells; 2022 May; 11(9):. PubMed ID: 35563880
[TBL] [Abstract][Full Text] [Related]
7. MMP-2 is required for bone marrow stromal cell support of pro-B-cell chemotaxis.
Clutter SD; Fortney J; Gibson LF
Exp Hematol; 2005 Oct; 33(10):1192-200. PubMed ID: 16219541
[TBL] [Abstract][Full Text] [Related]
8. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
Zdzisińska B; Bojarska-Junak A; Walter-Croneck A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):153-63. PubMed ID: 20157786
[TBL] [Abstract][Full Text] [Related]
10. miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats.
Cui C; Ye X; Chopp M; Venkat P; Zacharek A; Yan T; Ning R; Yu P; Cui G; Chen J
Stem Cells Transl Med; 2016 Dec; 5(12):1656-1667. PubMed ID: 27460851
[TBL] [Abstract][Full Text] [Related]
11. [Regulation of miRNA-15a/-16 expression on the drug resistance of myeloma cells].
Zang MR; Li F; An G; Xie ZQ; Li CH; Yu Z; Xu Y; Qiu LG; Hao M
Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1100-3. PubMed ID: 22781767
[TBL] [Abstract][Full Text] [Related]
12. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M-induced upregulation of SDF-1 improves Bone marrow stromal cell migration in a rat middle cerebral artery occlusion stroke model.
Han J; Feng Z; Xie Y; Li F; Lv B; Hua T; Zhang Z; Sun C; Su D; Ouyang Q; Cai Y; Zou Y; Tang Y; Sun H; Jiang X
Exp Neurol; 2019 Mar; 313():49-59. PubMed ID: 30213507
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.
Corso A; Ferretti E; Lunghi M; Zappasodi P; Mangiacavalli S; De Amici M; Rusconi C; Varettoni M; Lazzarino M
Cancer; 2005 Jul; 104(1):118-25. PubMed ID: 15895374
[TBL] [Abstract][Full Text] [Related]
15. SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43.
Jin J; Wang T; Wang Y; Chen S; Li Z; Li X; Zhang J; Wang J
Int J Oncol; 2017 Dec; 51(6):1694-1704. PubMed ID: 29075794
[TBL] [Abstract][Full Text] [Related]
16. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney.
Liu N; Tian J; Cheng J; Zhang J
J Cell Biochem; 2013 Dec; 114(12):2677-89. PubMed ID: 23794207
[TBL] [Abstract][Full Text] [Related]
17. High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomib.
Malek E; Driscoll JJ
Oncotarget; 2016 Jun; 7(25):38523-38538. PubMed ID: 27229530
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
Nefedova Y; Landowski TH; Dalton WS
Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
